A recent branch of cardiovascular medicine called molecular cardiology seeks to use molecular biology methods for the mechanistic analysis, detection, diagnosis, and therapy of cardiovascular illness. Its main objective is to identify novel pathways that affect cardiac hypertrophy, ageing, and metabolic disorders, paying close attention to how each discovery might be translated into fresh bedside methods and tactics.
Cellular cardiology: Heart failure is among the leading causes of death in the modern world. The study of the heart or circulatory system at the cellular level is known as cellular cardiology. In this molecular cardiology, the researchers found that the cells in various heart regions differed significantly from one another and that each part of the organ included a distinct group of cells, revealing various developmental origins and possibly varying responses to therapies. The molecular and cellular biology methods that are most frequently employed include:
Title : Managing total chronic coronary occlusion: Noninvasive External Counterpulsation (ECP) induces collaterogenesis, relieving ischemia, as demonstrated by quantitative PET myocardial perfusion imaging: ECP is a cost-effective alternative to high risk PCI
Michael E Merhige, State University of NY at Buffalo, United States
Title : Novel signaling pathways and therapeutic options for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : Rheumatic heart disease in the 21st century: Challenges and opportunities
Susy Kotit, Aswan Heart Centre, Egypt
Title : Rationale for the prevention or therapy of sudden cardiac death in heart failure
Naranjan Dhalla, St. Boniface Hospital Albrechtsen Research Centre, Canada
Title : Patient adherence to ischemic heart disease treatment
Moacyr Nobre, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), Brazil
Title : Metabolic dysfunction spilling over to the heart
Ahdy W Helmy, Indiana University School of Medicine, United States